Livostin en es it fr

Livostin Brand names, Livostin Analogs

Livostin Brand Names Mixture

  • No information avaliable

Livostin Chemical_Formula


Livostin RX_link

Livostin fda sheet

Livostin FDA

Livostin msds (material safety sheet)

Livostin Synthesis Reference

No information avaliable

Livostin Molecular Weight

351.348 g/mol

Livostin Melting Point

239-240.5 oC

Livostin H2O Solubility

27.2 mg/mL

Livostin State


Livostin LogP


Livostin Dosage Forms


Livostin Indication

For the treatment of bacterial infections of the respiratory tract (chronic bronchitis) and urinary tract, and as a pre-operative prophylactic to prevent urinary tract infection caused by: S.pneumoniae, H.influenzae, S.aureus, P.aeruginosa, E. cloacae, P. mirabilis, C. civersus, S. asprphyticus, E.coli, and K.pneumoniae.

Livostin Pharmacology

Lomefloxacin is a fluoroquinolone antibiotic used to treat chronic bronchitis, as well as complicated and uncomplicated urinary tract infections. It is also used as a prophylactic or preventative treatment to prevent urinary tract infections in patients undergoing transrectal or transurethral surgical procedures. Flouroquinolones such as lomefloxacin possess excellent activity against gram-negative aerobic bacteria such as E.coli and Neisseria gonorrhoea as well as gram-positive bacteria including S. pneumoniae and Staphylococcus aureus. They also posses effective activity against shigella, salmonella, campylobacter, gonococcal organisms, and multi drug resistant pseudomonas and enterobacter.

Livostin Absorption

Rapid and nearly complete with approximately 95% to 98% of a single oral dose being absorbed.

Livostin side effects and Toxicity

Adverse reactions include peripheral neuropathy, nervousness, agitation, anxiety, and phototoxic events (rash, itching, burning) due to sunlight exposure.

Livostin Patient Information

Livostin Organisms Affected

Enteric bacteria and other eubacteria